A Cluster-Randomized Trial of Labelled Cash Transfers for Uptake of Care for Chronic Conditions Among Middle-Aged and Older Adults in Burkina Faso

A Cluster-Randomized Trial of Labelled Cash Transfers for Uptake of Care for Chronic Conditions Among Middle-Aged and Older Adults in Burkina Faso

Nature Human Behaviour
Nature Human BehaviourApr 20, 2026

Why It Matters

Improving linkage to chronic‑disease care can curb the growing NCD burden in sub‑Saharan Africa and reduce long‑term health‑system costs. The trial demonstrates that modest financial nudges can meaningfully shift health‑seeking behavior among older, often underserved populations.

Key Takeaways

  • Cash transfers raised clinic visits by 27% versus control
  • Medication adherence improved 15% in the incentive group
  • Cost per extra patient linked to care was about $45
  • Labelled cash incentives proved feasible in rural Burkina Faso
  • Study supports scaling financial nudges for NCD management in LMICs

Pulse Analysis

The rising tide of non‑communicable diseases (NCDs) in sub‑Saharan Africa has outpaced health‑system capacity, leaving many middle‑aged and older adults without regular care for hypertension, diabetes, and related conditions. Traditional supply‑side solutions—such as expanding clinics or training staff—are essential but often insufficient to overcome demand‑side barriers like transport costs, opportunity costs of time, and limited health literacy. By attaching a modest, clearly labelled cash incentive to a specific health action, the Burkina Faso trial leveraged behavioral economics to address these barriers directly, turning a financial nudge into a catalyst for care‑seeking.

The trial’s design—30 villages randomly assigned to receive either the cash incentive or standard outreach—allowed a rigorous assessment of impact. Over a six‑month follow‑up, participants who received the $10 transfer were 27% more likely to attend a primary‑care visit for NCD screening, and among those diagnosed, medication adherence rose by 15%. These gains were achieved at an incremental cost of roughly $45 per additional patient linked to care, a figure that compares favorably with many health‑system interventions in low‑resource settings. Moreover, the labelled nature of the transfer—explicitly tied to a health action—helped participants internalize the purpose of the money, reducing the risk of misuse and reinforcing the health message.

For policymakers and donors, the findings offer a compelling case for integrating conditional cash transfers into broader NCD strategies. The approach is adaptable: incentive amounts can be calibrated to local purchasing power, and the model can be combined with community health worker outreach or mobile health reminders to amplify reach. As countries in the region grapple with the dual burden of infectious diseases and NCDs, scalable demand‑side tools like labelled cash incentives could accelerate progress toward universal health coverage and improve long‑term health outcomes for vulnerable older adults.

A cluster-randomized trial of labelled cash transfers for uptake of care for chronic conditions among middle-aged and older adults in Burkina Faso

Comments

Want to join the conversation?

Loading comments...